Business
Naira strengthens against Dollar official market, trades at N856.57/$
The Nigerian currency, the Naira further gained against the dollar on Monday, 8th December 2024 at the official Nigerian Autonomous Foreign Exchange Market (Window) signifying the third gain in the New Year.
The domestic currency appreciated to/$1 at the close of business, data from the NAFEM window where forex is officially traded, showed.
This represents a gain of N12.56 in the local currency compared to the N869.13 it closed the previous day.
READ ALSO: Naira reverses losing streak, appreciates to N895.23/$1 at official market
The intraday high was N1,185 while the intraday low was N720.00 representing a spread of N465.
However, the naira closed flat against the parallel window closing at N1245/$1 same as the last trading day on Friday January 5, 2024 while peer-to-peer traders quoted around N1251.26/$1.
The naira however lost N10 against the British pound to close at N1,560/£1 as against the N1,550/£1 it traded on Friday.
Again, the Canadian dollar maintained a bit of stability to close at N980/CA$1, the same as its closing price yesterday.
The naira however closed flat against the Euro to slump to ₦1,320/€1 same as the previous closing price of ₦1,320/€1 the previous day.
-
Football7 days agoBallon d’Or 2026: Yamal, Mbappe, Kane emerge early favourites
-
Football6 days agoPost-World Cup Shake-Up: Managerial changes, record transfers dominate football headlines
-
Football6 days agoWAFCON 2026: Super Falcons target winning start as Nigeria face debutants Malawi
-
Energy5 days agoNigeria wastes enough gas to Ggenerate 62,400GWh of electricity amid deepening energy crisis — NOSDRA
-
Latest1 week agoAccountability group questions ₦962.8bn Allocation for empowerment projects, official vehicles in 2026 budget
-
Business2 days agoCooking gas dealers slash prices amid intensifying market competition
-
Business2 days agoInformation Minister, VON DG to lead ARCON’s 2026 Advertising Industry Colloquium
-
Health5 days agoFauci’s personal diaries fuel renewed scrutiny of COVID-19 vaccine safety


